Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : KM10544
Therapeutic Area : Oncology
Study Phase : Preclinical
Sponsor : Emmaus Life Sciences
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Emmaus intends to advance the licensed technology to complete in-vivo studies to determine disease selection for KM10544 which, if successful, would be followed by Investigational New Drug enabling studies.
Brand Name : KM10544
Molecule Type : Undisclosed
Upfront Cash : Undisclosed
October 12, 2021
Lead Product(s) : KM10544
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Sponsor : Emmaus Life Sciences
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?